TCM
ELV icon

Tradewinds Capital Management’s Elevance Health ELV Stock Holding History

Tradewinds Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48
Closed -$25K – 679
2024
Q3 		$25K Buy
48
+18
+60% +$9.62K 0.01% 246
2024
Q2 		$16.3K Hold
30
– – ﹤0.01% 279
2024
Q1 		$15.6K Buy
+30
New +$14.9K ﹤0.01% 268
2022
Q1 		– Sell
-200
Closed -$93K – 792
2021
Q4 		$93K Buy
+200
New +$84.1K 0.01% 182

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Tradewinds Capital Management's ELV Position: Q4 2024 in Review

Tradewinds Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 48 shares — an estimated $25K sold.

Tradewinds Capital Management first reported a position in ELV in Q4 2021 and held it in 4 quarters. The position peaked at $93K in Q4 2021. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Tradewinds Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Tradewinds Capital Management sold 48 Elevance Health shares in Q4 2024, an estimated $25K.
  • Tradewinds Capital Management first reported a position in Elevance Health in Q4 2021 and held it in 4 quarters.
  • Tradewinds Capital Management's Elevance Health position peaked at $93K in Q4 2021.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Tradewinds Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.